The median survivals of control, CD95 knockout, and CD95L knockout tumor-bearing mice did not differ significantly, being 193, 209, and 202 days, respectively, in the S-24 model and 18.5, 20, and 20 days in the ZH-161 model (Fig. 5A, B). This evidence concerns the gene FASLG and neoplasm.